Hospitals are scrambling for plans to determine if health care workers can receive the Covid-19 vaccine first, with the expectation of an initial supply of the amount needed to vaccinate all high-priority employees. Enough is expected to deliver the December vaccine to about 200 million people, according to federal officials. …
Read More »The Covid-19 vaccine faces public concerns over rollout safety
Governments are moving toward approving the first vaccines to contain Covid-19, but public concerns about dosage safety are threatening to undermine those efforts. A survey by the University of Hamburg found that about 40% of respondents in seven European countries were hesitant or unwilling to prepare for the Covid-19 vaccine …
Read More »Gene editing shows promise in sickle-cell disease
Drug development for sickle-cell disease, largely neglected for decades, is becoming a crowded field: two papers published on Saturday in the New England Journal of Medicine give promising results from a study of experimental therapies, including Crisper gene editing for the disease. In addition, Beam Therapeutics Inc. The American Society …
Read More »Covid-19 vaccine test from AstraZeneca, Ox Xford U.S. Can resume in
Federal health regulators have ruled out a leading Covid-19 vaccine candidate from AstraZeneca AZN in the U.S. Allowed the study to resume. 0.08% According to a person familiar with the matter and content reviewed by Wall Street Journal, PLC and Oxford University. U.S. The Food and Drug Administration wrapped up …
Read More »How Pfizer Partner Bioentech Coronavirus Vaccine Leads the Race
Mainz, Germany On a Friday in late January, Ugur Sahin received an email with bad news: A new study of a deadly new coronavirus in China suggests it is more contagious than previously thought. He believed the outbreak was likely to be an epidemic. The following Monday, the chief executive …
Read More »